AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
27 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
26 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
25 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
24 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
23 Jan 2012 07:01 AM
RNS
Transaction in Own Shares
20 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jan 2012 07:00 AM
RNS
FDA COMPLETE RESPONSE LETTER FOR DAPAGLIFLOZIN
18 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
16 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
13 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
12 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
11 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
10 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
09 Jan 2012 07:00 AM
RNS
Reaffirms financial guidance for 2011
09 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
06 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
05 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
04 Jan 2012 11:03 AM
RNS
Director/PDMR Shareholding
04 Jan 2012 07:00 AM
RNS
Transaction in Own Shares
03 Jan 2012 04:00 PM
RNS
Total Voting Rights
29 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
23 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
22 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
21 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
20 Dec 2011 07:00 AM
RNS
UPDATES ON OLAPARIB AND TC-5214 PROGRAMMES
20 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
19 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
16 Dec 2011 01:14 PM
RNS
Transaction in Own Shares
15 Dec 2011 04:30 PM
RNS
Share Repurchase Programme
15 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
14 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
13 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
12 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2011 07:00 AM
RNS
AstraZeneca streamlines US sales organisation
08 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
07 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
06 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
05 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2011 04:30 PM
RNS
Blocklisting Interim Review
01 Dec 2011 04:00 PM
RNS
Total Voting Rights
01 Dec 2011 07:00 AM
RNS
Transaction in Own Shares
30 Nov 2011 07:00 AM
RNS
Transaction in Own Shares
29 Nov 2011 07:00 AM
RNS
Komboglyze gets EU marketing authorisation
29 Nov 2011 07:00 AM
RNS
Transaction in Own Shares
28 Nov 2011 07:00 AM
RNS
Transaction in Own Shares
25 Nov 2011 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100